A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors (Q37554906)
Jump to navigation
Jump to search
scientific article published on 24 March 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors |
scientific article published on 24 March 2013 |
Statements
1 reference
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors (English)
1 reference
Shubham Pant
1 reference
Howard A Burris
1 reference
Kathleen Moore
1 reference
Johanna C Bendell
1 reference
Carla Kurkjian
1 reference
Suzanne F Jones
1 reference
Ofir Moreno
1 reference
John G Kuhn
1 reference
Scott McMeekin
1 reference
Jeffrey R Infante
1 reference
24 March 2013
1 reference
1 reference
87-93
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference